Sanofi (SNY)

• Market cap: $123B
• 1 day: 0.34%
• 5 days: -0.75%
• 1 month: 1.66%
• 3 months: -3.99%
• 6 months: -8.46%
• Year to date: 4.38%
• 1 year: -10.61%
• 5 years: -2.61%
• 10 years: 2.38%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Employees: 82,878

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

6% more repeat investments, than reductions

Existing positions increased: 267 | Existing positions reduced: 253

0% more call options, than puts

Call options by funds: $57M | Put options by funds: $56.8M

7% less funds holding

Funds holding: 757 [Q1] → 704 (-53) [Q2]

11.12% less ownership

Funds ownership: 21.06% [Q1] → 9.93% (-11.12%) [Q2]

18% less capital invested

Capital invested by funds: $14.4B [Q1] → $11.8B (-$2.62B) [Q2]

30% less first-time investments, than exits

New positions opened: 69 | Existing positions closed: 98

67% less funds holding in top 10

Funds holding in top 10: 12 [Q1] → 4 (-8) [Q2]